Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: microbiological eradication outcomes

PURPOSE: To assess clinical antimicrobial efficacy results obtained with besifloxacin ophthalmic suspension, 0.6%, administered three times a day (TID) for 5 days, integrated across three clinical trials of bacterial conjunctivitis and to investigate any microbiological eradication failures. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Morris, Timothy W, Gearinger, Lynne S, Usner, Dale W, Paterno, Michael R, DeCory, Heleen H, Comstock, Timothy L, Haas, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198409/
https://www.ncbi.nlm.nih.gov/pubmed/22034555
http://dx.doi.org/10.2147/OPTH.S23518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198409/
https://www.ncbi.nlm.nih.gov/pubmed/22034555
http://dx.doi.org/10.2147/OPTH.S23518

Ejemplares similares